Prices of 98 drugs not fixed due to non availability of information

Published On 2015-11-06 08:41 GMT | Update On 2015-11-06 08:41 GMT

New Delhi: The central government has not been able to fix the price of 98 drugs used for treating various diseases such as tuberculosis, cardiac conditions, anemia, malaria and infections due to non-availability of information.

"NPPA prepared list of 98 medicines included in Schedule - I of DPCO, 2013 for which no information is available and prices could not be fixed/notified," National Pharmaceutical Pricing Authority said in a statement on its website.

In an earlier statement in July, NPPA had asked various stakeholders to provide related data in 30 days.

It had sought data/information about these 98 formulations from all state governments and UTs, Drug Controller General of India, drug controllers of states and UTs, IMS health, Pharma Trac and apex pharma organisations such as OPPI, IDMA, IPA, among others, and trade associations.

The authority had then said that it fixed the ceiling price of 530 formulations from the list of essential medicines included in Schedule-1 of DPCO, 2013.

At present, the government caps prices of essential drugs based on the simple average of all medicines in a particular therapeutic segment with sales of more than 1 per cent.

In the case of non-scheduled drugs, companies are allowed to hike prices by only up to 10 per cent in a year.

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She is a member of the Association of Healthcare Journalists. She can be contacted at meghna@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Prices of 98 drugs not fixed due to non availability of information

Similar News

Odisha CM inugurates 73 Ama Hospitals and dialysis centres in 15 Odisha districts

Unfortunate: PG Orthopedic Student at SSKM Hospital succumbs to dengue

GMC Rajouri gets dermatology wing to treat skin related cancer, diseases

LLRM Medical College: Another doctor booked for beating up patient kin

NHA Posts Decentralized Health Protocol (DHP) on Github platform asks private players to commit

Pregabalin effective in relieving symptoms in Functional Dyspepsia, finds study

JnK starts District Residency Program for PG Medical Students

Arthritis Drug linked to Heart-Related Problems and Cancer by FDA